Related Experiment Video
Updated: Feb 22, 2026
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Temporal Hemodynamic Patterns in Cardiogenic Shock Treated With Isolated Percutaneous Ventricular Assist Device and
Kanako Teramoto1, Keita Saku2, Yuki Ikeda3
1Department of Biostatistics, National Cerebral and Cardiovascular Center Research Institute, Suita, Japan.
Background:
This study aimed to describe hemodynamic trends in patients with cardiogenic shock who received either isolated microaxial flow pump (mAFP) support or additional mAFP on venoarterial extracorporeal membrane oxygenation support (ie, VA-ECMO + mAFP). Trends also were analyzed by hospital survival in each group.
Methods:
Using mixed-effect models, we analyzed hemodynamic indices from pre-, post-, and 24 hours after mAFP installation to immediately before device explantation in patients from the UNLOADERS-PVAD (UNLoading and heart recOvery with ADvanced mEchanical ciRculatory Support: optimal management of Percutaneous Ventricular Assist Device) Registry, a Japanese multicenter registry of patients with cardiogenic shock receiving mAFP.
Results:
Hemodynamic indices from 409 patients (mean age 67 years, 75% male; 206 with isolated mAFP and 203 with VA-ECMO + mAFP) were analyzed. From immediately before mAFP installation to immediately before mAFP explantation, the mAFP group achieved an 11.8-mm Hg decrease in pulmonary artery wedge pressure, a 5.8-mm Hg decrease in right atrial pressure, and a 1.32 L/min increase in cardiac output (COPAC). Similarly, the ECMO + mAFP group showed a 2.8 L/min and 0.4 W increase in COPAC and cardiac power output, respectively. Changing patterns of hemodynamic indices were comparable between survivors and nonsurvivors with isolated mAFP support. In the ECMO + mAFP group, survivors demonstrated additional increases in COPAC, aortic pulsatility index, and myocardial performance score as well as reductions in pulmonary artery wedge pressure and diastolic pulmonary arterial pressure after VA-ECMO explantation.
Conclusions:
Patients with mAFP for cardiogenic shock exhibited progressive decreases in atrial pressures and increases in cardiac output, with distinct patterns in survivors receiving mAFP in addition to VA-ECMO. Hemodynamic monitoring may help determine the extent of cardiac recovery during combination therapy.
Related Concept Videos
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
01:24Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
01:30Cardiomyopathy II: Dilated Cardiomyopathy